These results suggest that GSPE may activate the Nrf2 signaling pathway, which antagonizes glucolipotoxicity-induced oxidative damage and inhibits ferroptosis in β cells, making it a possible treatment for ferroptosis in T2DM. The gene discussed is NFE2L2; the disease is type 2 diabetes mellitus.